Optimizing the Quality of Breast Cancer Biomarker Use at Duke Cancer Institute

Por Kamal, Arif H., Power, Steve, Broadwater, Gloria, Holland, Audrey R., Marcom, Paul K.
Publicado no J Natl Compr Canc Netw (2014)

Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy

Por Kimmick, Gretchen, Edmond, Sara N., Bosworth, Hayden B., Peppercorn, Jeffrey, Marcom, Paul K., Blackwell, Kimberly, Keefe, Francis J., Shelby, Rebecca A.
Publicado no Breast (2015)

Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

Por Armstrong, Andrew J., Marengo, Matthew S., Oltean, Sebastian, Kemeny, Gabor, Bitting, Rhonda L., Turnbull, James, Herold, Christina I., Marcom, Paul K., George, Daniel, Garcia-Blanco, Mariano A.
Publicado em 2011

Higher Symptom Burden is Associated with Lower Function in Women Taking Adjuvant Endocrine Therapy for Breast Cancer

Por Sitlinger, Andrea, Shelby, Rebecca A., Van Denburg, Alyssa N., White, Heidi, Edmond, Sarah N., Marcom, Paul K, Bosworth, Hayden B., Keefe, Francis J., Kimmick, Gretchen G.
Publicado no J Geriatr Oncol (2018)

Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer

Por Silva, Grace O., He, Xiaping, Parker, Joel S., Gatza, Michael L., Carey, Lisa A., Hou, Jack P., Moulder, Stacy L., Marcom, Paul K., Ma, Jian, Rosen, Jeffrey M., Perou, Charles M.
Publicado no Breast Cancer Res Treat (2015)

Novel Sampling Strategies to Enable Microarray Gene Expression Signatures in Breast Cancer: A Study to Determine Feasibility and Reproducibility in the Context of Clinical Care

Por Tebbit, Christopher L., Zhai, Jun, Untch, Brian R., Ellis, Matthew J., Dressman, Holly K., Bentley, Rex C., Baker, Jay A., Marcom, Paul K., Nevins, Joseph R., Marks, Jeffrey R., Olson, John A.
Publicado em 2009

Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome

Por Barry, William T., Kernagis, Dawn N., Dressman, Holly K., Griffis, Ryan J., Hunter, J'Vonne D., Olson, John A., Marks, Jeff R., Ginsburg, Geoffrey S., Marcom, Paul K., Nevins, Joseph R., Geradts, Joseph, Datto, Michael B.
Publicado em 2010

Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial

Por Olson, John A, Budd, G Thomas, Carey, Lisa A, Harris, Lyndsay A, Esserman, Laura J, Fleming, Gini F, Marcom, Paul K, Leight, George S, Giuntoli, Therese, Commean, Paul, Bae, Kyongtae, Luo, Jingqin, Ellis, Matthew J
Publicado em 2009

A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer

Por McRee, Autumn J., Marcom, Paul K., Moore, Dominic T., Zamboni, William C., Kornblum, Zachary A., Hu, Zhiyuan, Phipps, Rachel, Anders, Carey K., Reeder-Hayes, Katherine, Carey, Lisa A., Weck, Karen E., Perou, Charles M., Dees, E. Claire
Publicado no Clin Breast Cancer (2017)

Vaccine-induced memory CD8+ T cells provide clinical benefit in HER2 expressing breast cancer: a mouse to human translational study

Por Crosby, Erika J., Gwin, William, Blackwell, Kimberly, Marcom, Paul K., Chang, Serena, Maecker, Holden T, Broadwater, Gloria, Hyslop, Terry, Kim, Sungjin, Rogatko, Andre, Lubkov, Veronica, Snyder, Joshua C., Osada, Takuya, Hobeika, Amy C., Morse, Michael A., Lyerly, H. Kim, Hartman, Zachary C.
Publicado no Clin Cancer Res (2019)